ODB Funded (tablets, oral liquid)

1% to 10%:

• Central nervous system: Dizziness (1%)
• Dermatologic: Diaper rash (2%), genital pruritus (2%)
• Gastrointestinal: Nausea (4%), diarrhea (3%), abdominal pain (1%), vomiting (1%)
• Genitourinary: Vaginitis
• Hepatic: Increased serum transaminases (2%)
• Infection: Superinfection

• Evaluate renal function before and during therapy
• With prolonged therapy, monitor coagulation tests, CBC, and liver function tests periodically
• Monitor for signs of anaphylaxis during first dose

• Food delays cefprozil absorption
• Management: May administer with food